Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. [electronic resource]
Producer: 20111004Description: 42-7 p. digitalISSN:- 1938-0674
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Bevacizumab
- Biomarkers, Tumor
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Disease Progression
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Irinotecan
- Italy
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Risk
- Survival Analysis
- Vitamin B Complex -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.